Dark

NRSN
NeuroSense Therapeutics Ltd.
stock NASDAQ

At Close

Aug 19, 2026 12:59:44 PM EDT

0.3700USD-4.110%(-0.0160)1,454,501

0.2300Bid 0.4100Ask 0.1900Spread

Pre-market

Aug 18, 2026 9:19:30 AM EDT

0.4200USD+9.948%(+0.0380)0

After-hours

Aug 18, 2026 4:34:30 PM EDT

0.3900USD-2.010%(-0.0100)0

Overview HistoricalExchangesShortsMore

open chart

Market Cap

15.07M

Industry

Biotechnology

NRSN Stats

Avg. Vol. 10 Day

231,545

Avg. Vol. 30 Day

288,936

Employees

Market Cap

15,068,673

Shares Out.

37,766,098

On/Off Exchange

48%/52%

6 Month Beta

1.12

1 Year Beta

0.93

2 Year Beta

0.65

3 Year Beta

0.67

52 Week Low

0.38

52 Week High

1.98

SMA50

0.64

SMA200

0.83

1 Week

-14.87%

1 Month

-42.13%

3 Month

-47.64%

6 Month

-54.68%

1 Year

-65.60%

2 Year

-47.91%

5 Year

-90.12%

Profile

advancing research, development and therapy for als. neurosense therapeutics is a biotech company focusing on the development of mirnas as a novel treatment for als. currently preparing for a first clinical study in patients in usa

NRSN Stock Summary

NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) stock price today is $0.3700, and today's volume is 1,454,501. NRSN is down -4.110% today. The 30 day average volume is 288,936. NRSN market cap is 15.07M with 37,766,098 shares outstanding.

.dark-mode .r8Z61W{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .r8Z61W{ color: #333333; background-color: white; border: 2px solid #333333; }NRSNNeuroSense Therapeutics Ltd.stock NASDAQ

NRSN Stock Summary

NRSN
NeuroSense Therapeutics Ltd.
stock NASDAQ